Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 3370
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT07063810 NEO-REEDUC - Mixed Reality for Motor Rehabilitation: a Prospective, Mul… |
Mixed Reality Rehabilitation | Parkinson | Non applicable | COMPLETED | En attente / non publié | Slb Pharma | France · Continuing care and rehabilitation center (S… | 2025-06-30 → 2026-04-17 | Ouvrir |
| NCT07756268 Phase Ib/II Study of SYS6020 in Relapsing/Refractory Multiple Sclerosis |
SYS6020 injection | SEP | Phase 1/2 | NOT_YET_RECRUITING | En attente / non publié | CSPC ZhongQi Pharmaceutical Techn… | China · Tongji Hospital, Tongji Medical College of HU… | 2026-09-16 → 2029-02-07 | Ouvrir |
| NCT04745299 ALSummit — Evaluation the Efficacy and Safety of Mutiple Lenzumestrocel… |
Lenzumestrocel | Sclérose latérale amyotrophique | Phase 3 | COMPLETED | En attente / non publié | Corestemchemon, Inc. | South Korea · Hanyang university hospital, Seoul, Sou… | 2021-02-24 → 2024-11-13 | Ouvrir |
| NCT00140218 R(+) Pramipexole in Early Amyotrophic Lateral Sclerosis |
R(+) pramipexole dihydrochloride … | Sclérose latérale amyotrophique | Phase 1/2 | COMPLETED | En attente / non publié | Bennett, James P., Jr., M.D., Ph.… | United States · David Lacomis MD, Pittsburgh, United … | 2005-08 → 2006-12 | Ouvrir |
| NCT03293069 FAIR-ALS II — Conservative Iron Chelation as a Disease-modifying Strate… |
deferiprone | Sclérose latérale amyotrophique | Phase 2/3 | COMPLETED | En attente / non publié | University Hospital, Lille | France · Aphm Hopital La Timone, Marseille, France | … | 2019-01-30 → 2024-05-06 | Ouvrir |
| NCT00600873 R(+)PPX High Dose Treatment of ALS |
R(+) pramipexole dihydrochloride … | Sclérose latérale amyotrophique | Phase 1/2 | COMPLETED | En attente / non publié | Bennett, James P., Jr., M.D., Ph.… | United States · University of Virginia, Charlottesvil… | 2007-08 → 2009-01 | Ouvrir |
| NCT01051882 Autologous Cultured Mesenchymal Bone Marrow Stromal Cells Secreting Neu… |
MSC-NTF cells transplantation (IM) | Sclérose latérale amyotrophique | Phase 1/2 | COMPLETED | En attente / non publié | Brainstorm-Cell Therapeutics | Israel · Hadassah Medical Organization, Jerusalem, Is… | 2011-06 → 2013-03 | Ouvrir |
| NCT07743268 Personalized Antisense Oligonucleotide Therapy for Participants With TA… |
nL-TARDB-006 | Sclérose latérale amyotrophique | Phase 1/2 | ENROLLING_BY_INVITATION | En attente / non publié | n-Lorem Foundation | United States · Columbia University, Irving Medical C… | 2026-02-19 → 2028-02 | Ouvrir |
| NCT07161999 ALSTARS — Study of COYA 302 for the Treatment of ALS |
COYA 302 | Sclérose latérale amyotrophique | Phase 2/3 | RECRUITING | En attente / non publié | Coya Therapeutics | United States, Canada · Austin Neuromuscular Center; … | 2025-10-01 → 2027-07 | Ouvrir |
| NCT07571486 Son-ALS — Therapeutic Approach of Repeated Transient Blood-brain Barrie… |
SonoCloud-4 (SC4) device | Sclérose latérale amyotrophique | Phase 1/2 | RECRUITING | En attente / non publié | Assistance Publique - Hôpitaux de… | France · Hôpital Pitié-Salpêtrière, Paris, France | 2026-07-15 → 2031-07-15 | Ouvrir |
| NCT04744532 iPSC-based Drug Repurposing for ALS Medicine (iDReAM) Study |
Bosutinib (Phase 1 part) | Sclérose latérale amyotrophique | Phase 1/2 | COMPLETED | En attente / non publié | Kyoto University | Japan · Hiroshima University, Hiroshima, Japan | Kita… | 2019-03-19 → 2024-07-31 | Ouvrir |
| NCT05265273 A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Ge… |
Nipocalimab | Myasthénie | Phase 2/3 | RECRUITING | En attente / non publié | Janssen Research & Development, L… | United States, Japan, Netherlands, Poland · C.S. Mott… | 2022-07-20 → 2029-07-02 | Ouvrir |
| NCT06055959 ziMyG — A Study to Evaluate Subcutaneous Zilucoplan in Pediatric Partic… |
Zilucoplan | Myasthénie | Phase 2/3 | RECRUITING | En attente / non publié | UCB Biopharma SRL | United States, Italy, Poland, South Korea, United Kin… | 2024-10-16 → 2026-12-25 | Ouvrir |
| NCT07596901 Study of Aritinercept in Patients With Generalized Myasthenia Gravis |
Aritinercept | Myasthénie | Phase 1/2 | RECRUITING | En attente / non publié | Aurinia Pharmaceuticals Inc. | United States · Aurinia Investigational Site, Altamon… | 2026-04-22 → 2029-03-02 | Ouvrir |
| NCT06447597 A Clinical Study of B007 in the Treatment of Generalized Myasthenia Gra… |
B007 | Myasthénie | Phase 2/3 | RECRUITING | En attente / non publié | Shanghai Jiaolian Drug Research a… | China · Affiliated Hospital of Zunyi Medical College,… | 2024-07-01 → 2026-12-30 | Ouvrir |
| NCT06540144 An Extension Study Evaluating 6-week Treatment Cycles of Rozanolixizuma… |
rozanolixizumab | Myasthénie | Phase 3 | ENROLLING_BY_INVITATION | En attente / non publié | UCB Biopharma SRL | Italy, Japan, Poland, Taiwan, Turkey (Türkiye) · Mg00… | 2024-10-08 → 2027-08-17 | Ouvrir |
| NCT06359041 RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Pa… |
CABA-201 | Myasthénie | Phase 1/2 | RECRUITING | En attente / non publié | Cabaletta Bio | United States · Baylor College of Medicine Neurology … | 2024-12-17 → 2029-09 | Ouvrir |
| NCT04146051 Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG) |
Descartes-08 | Myasthénie | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Cartesian Therapeutics | United States, Canada · Allegheny Health Network, Pit… | 2019-12-04 → 2026-09-30 | Ouvrir |
| NCT07766148 Scapular Stabilization Exercises Combined With Thoracic Mobilization in… |
Scapular Stabilization Exercises … | Myopathies | Non applicable | COMPLETED | En attente / non publié | University of Lahore | Pakistan · The University of Lahore Teaching Hospital… | 2026-02-24 → 2026-07-21 | Ouvrir |
| NCT03368742 IGNITE DMD — Microdystrophin Gene Transfer Study in Adolescents and Chi… |
SGT-001 | Myopathies | Phase 1/2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Solid Biosciences Inc. | United States · David Geffen School of Medicine at UC… | 2017-12-06 → 2026-10-15 | Ouvrir |
| NCT06131983 Study of SRP-1001 in Adult and Adolescent Participants With Facioscapul… |
SRP-1001 for Injection | Myopathies | Phase 1/2 | RECRUITING | En attente / non publié | Sarepta Therapeutics, Inc. | Australia, Canada, Germany, Italy, Netherlands, New Z… | 2024-06-19 → 2028-12-31 | Ouvrir |
| NCT05524883 DELIVER — Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmaco… |
DYNE-251 | Myopathies | Phase 1/2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Dyne Therapeutics | United States, Australia, Belgium, Canada, Ireland, I… | 2022-08-12 → 2031-09 | Ouvrir |
| NCT06138743 Study of SRP-1003 in Participants With Type 1 Myotonic Dystrophy |
SRP-1003 IV Infusion | Myopathies | Phase 1/2 | RECRUITING | En attente / non publié | Sarepta Therapeutics, Inc. | Australia, Belgium, Canada, France, Germany, Italy, N… | 2024-03-04 → 2026-12-31 | Ouvrir |
| NCT07038824 ELEVATE-45 — A Study in Participants With Duchenne Muscular Dystrophy A… |
ENTR-601-45 | Myopathies | Phase 1/2 | RECRUITING | En attente / non publié | Entrada Therapeutics, Inc. | Belgium, Italy, Netherlands, Spain, United Kingdom · … | 2025-08-30 → 2029-03-01 | Ouvrir |
| NCT07037862 ELEVATE-44 — A Study in Participants With Duchenne Muscular Dystrophy A… |
ENTR-601-44 | Myopathies | Phase 1/2 | RECRUITING | En attente / non publié | Entrada Therapeutics, Inc. | Belgium, Italy, Spain, United Kingdom · Alder Hey Chi… | 2025-06-30 → 2029-03-28 | Ouvrir |